KRAS G12C inhibitor 29

KRAS G12C inhibitor 29 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 3. KRAS G12C inhibitor 29 can be used for the research of cancer[1].

Product Specifications

CAS Number

[847337-63-7]

UNSPSC

12352005

Target

Ras

Type

Reference compound

Related Pathways

GPCR/G Protein; MAPK/ERK Pathway

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/kras-g12c-inhibitor-29.html

Solubility

10 mM in DMSO

Smiles

O=C(N1CC2=C(F)C=CC=C2Cl)N(C)C3=C(N4C(N(C5=CC=CC(C)=C5)CCC4)=N3)C1=O

Molecular Formula

C23H21ClFN5O2

Molecular Weight

453.90

References & Citations

[1]Fan J, et, al. Substituted purine-2,6-dione compounds as kras inhibitors. WO2021252339A1.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

More Discoveries

Explore Other Products

Browse additional items from our catalog

NB100-1587 100 µL

Rabbit Polyclonal Rif1 Antibody

View Details

35208-1 500 Gms

Potato Dextrose Broth (PDB)

View Details

TU069366 1.0 mL

RAB12 3'UTR GFP Stable Cell Line

View Details

031458-ML750 100 µL

A2ML1, NT (A2ML1, CPAMD9, Alpha-2-macroglobulin-like protein 1, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9) (MaxLight 750) discontinued

View Details

sc-140645-V 200 µL

SSc5D shRNA (m) Lentiviral Particles

View Details

PV242601 500 ng

TTC15 Protein Vector (Mouse) (pPM-C-His)

View Details